InvestSMART

Medibank Private Limited (ASX: MPL) - Announcements

Current share price for MPL : $5.140 0.07 (1.38%)+

ASX company news and announcements for Medibank Private Limited (MPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibank Private Limited (MPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibank Private Limited (MPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibank Private Limited (MPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$14,156 Notification of cessation of securities - MPL 5 Oct 2022 8:15AM $3.520 $5.140 risen by 46.02%
$14,156 Notification regarding unquoted securities - MPL 27 Sep 2022 8:38AM $3.430 $5.140 risen by 49.85%
$14,156 Change of Director's Interest - David Koczkar 27 Sep 2022 8:34AM $3.430 $5.140 risen by 49.85%
$14,156 Proxy Form 2022 15 Sep 2022 8:22AM $3.560 $5.140 risen by 44.38%
$14,156 Notice of Annual General Meeting 2022 15 Sep 2022 8:22AM $3.560 $5.140 risen by 44.38%
$14,156 Appendix 4G 15 Sep 2022 8:21AM $3.560 $5.140 risen by 44.38%
$14,156 Annual Report 2022 15 Sep 2022 8:21AM $3.560 $5.140 risen by 44.38%
$14,156 Notification of cessation of securities - MPL 9 Sep 2022 8:33AM $3.500 $5.140 risen by 46.86%
$14,156 Notification regarding unquoted securities - MPL 7 Sep 2022 8:27AM $3.630 $5.140 risen by 41.60%
$14,156 Change of Director's Interest - David Koczkar 7 Sep 2022 8:23AM $3.630 $5.140 risen by 41.60%
$14,156 FY22 Results - Investor Presentation 18 Aug 2022 8:09AM $3.520 $5.140 risen by 46.02%
$14,156 FY22 Results - Media Release 18 Aug 2022 8:09AM $3.520 $5.140 risen by 46.02%
$14,156 Dividend/Distribution - MPL 18 Aug 2022 8:09AM $3.520 $5.140 risen by 46.02%
$14,156 FY22 Results - Appendix 4E and Financial Report 18 Aug 2022 8:09AM $3.520 $5.140 risen by 46.02%
$14,156 Notification of cessation of securities - MPL 12 Jul 2022 8:23AM $3.270 $5.140 risen by 57.19%
$14,156 Medibank announces $205m cash give back & premium deferral 22 Jun 2022 9:21AM $3.170 $5.140 risen by 62.15%
$14,156 Revised Share Trading Policy 12 May 2022 8:22AM $3.180 $5.140 risen by 61.64%
$14,156 FY22 Full Year - Key Dates 12 May 2022 8:22AM $3.180 $5.140 risen by 61.64%
$14,156 Macquarie Conference Presentation and FY22 Outlook update 3 May 2022 8:11AM $3.180 $5.140 risen by 61.64%
$14,156 Becoming a substantial holder 29 Apr 2022 8:01AM $3.160 $5.140 risen by 62.66%
$14,156 Notification of cessation of securities - MPL 11 Apr 2022 8:21AM $3.050 $5.140 risen by 68.52%
$14,156 Initial Director's Interest Notices - Fagg, Everingham 5 Apr 2022 8:27AM $3.030 $5.140 risen by 69.64%
$14,156 Change of Director's Interest - Gerard Dalbosco 29 Mar 2022 8:23AM $3.030 $5.140 risen by 69.64%
$14,156 Medibank appoints non-executive directors 25 Feb 2022 8:06AM $3.100 $5.140 risen by 65.81%
$14,156 HY22 Results - Investor Presentation 25 Feb 2022 8:06AM $3.100 $5.140 risen by 65.81%

201 - 225 of 512 results

Page 9 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.